Anesthesia & Pain Research

Anesthesia & Pain Research

Open Access
ISSN: 2639-846X
Case Report

A Successful Case of an Acquired Methemoglobinemia Treated with Methylene Blue

Authors: Almeida D, Remelhe M, Castro H, Machado H.

DOI: 10.33425/2639-846X.1056


Abstract

Methylene blue has been advocated for multiple indications, but data reporting its use on intoxication is rare. Acquired methemoglobinemia can be caused by a wide variety of chemicals and toxins and on severe cases, with high methemoglobin levels (>20%), methylene blue is the first line treatment. We describe a case report of a 45-year-old man with acute methemoglobinemia due to involuntary exposure to n-propyl nitrate. The patient came into the emergency department conscious, with profound peripheral and central cyanosis and oxygen saturation of 88% on air, with no response to oxygen supplementation. Arterial blood gas showed methemoglobin of 22.9%. Methylene blue was administered intravenously and symptoms improved dramatically, with control arterial blood gas with 2.6% of methemoglobin. Despite the rarity of occurrence of methemoglobinemia in occupational set, and since methylene blue is highly effective, a high degree of suspicious and good training aiming for prompt diagnosis is crucial in treating this emergency situation.

View / Download PDF
Citation: Almeida D, Remelhe M, Castro H, et al. A Successful Case of an Acquired Methemoglobinemia Treated with Methylene Blue. 2021; 5(2). DOI: 10.33425/2639-846X.1056
Editor-in-Chief
Kevin J. Sullivan
Kevin J. Sullivan
Pediatric Cardiac Anesthesiology and Pediatric Cardiac Critical Care Medicine | University of Florida

View full editorial board →
Journal Metrics
Impact Factor 3.3*
Acceptance Rate 78%
Time to first decision 6-8 Days
Submission to acceptance 10-12 Days